天澤信息(300209.SZ):持股5%以上股東劉智輝被違約處置141萬股
格隆匯 12 月 2日丨天澤信息(300209.SZ)公佈,公司近日收到公司持股5%以上股東劉智輝的函告,獲悉劉智輝與東吳證券進行的股票質押式回購交易發生違約,債權人東吳證券已對劉智輝相關股份進行違約處置。
截至2020年11月17日,劉智輝未履行《交易協議》項下的相關義務。根據《交易協議》規定,劉智輝構成違約。東吳證券已啟動違約處置程序,對劉智輝在東吳證券質押的公司股份進行處置。截至公告披露日,東吳證券已通過集中競價交易方式合計處置公司股份141萬股,佔公司總股本的0.33%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.